Researchers have discovered a way to extend the effectiveness of hormone therapy using a safe, inexpensive, and widely used class of drugs: corticosteroids. The new findings, published in Nature, pave the way for a clinical study starting in 2026.

It started with an unexpected e-mail. An US biotech company working on immunotherapies had picked up a strange signal: an protein appeared to bind to LAIR-1, a receptor that dampens immune cells. But why this was happening remained unclear. 

In a lab at the Netherlands’ UMC Utrecht, researcher Madelon Maurice was chasing a fundamental question: could the cell’s own machinery be harnessed to degrade, rather than merely inhibit, disease-causing proteins on the cell surface? What at first was basic science soon revealed itself as a radical new path in drug discovery.

The new research programme SPARC has been awarded a prestigious NWO Perspectief grant. This national funding supports large collaborations between researchers and industry to create innovations with real impact on society.

Every year, hundreds of participants cycle up Alpe d’Huez to raise funds for cancer research. 
For Oncode Institute, Alpe d'HuZes is more than a challenge — it’s a symbol of community, perseverance, and purpose.

As the year draws to a close, the Oncode community once again gathered at the iconic Royal Tropical Institute in Amsterdam for two days of science, inspiration, and connection.

During the Dutch Life Sciences Conference, Myriagon was announced as the winner of the Venture Challenge Fall 2025.

Researchers have discovered a potent group of T cells that physically cling to tumour cells. The study, led by Oncode Investigator Daniel Peeper and published in Nature, opens a new direction for improving immunotherapy.

Oncode Researchers develop a faster, more flexible way to find new medicines - no DNA tags required.

After 30 years of mystery, scientists reveal how BRCA2-deficient tumors evade chemotherapy, and how we might stop them.

From DNA to RNA to proteins, the event highlighted cutting-edge methods redefining how scientists map, measure, and model the central dogma.

Are you passionate about the latest digital marketing trends and looking to take your career to the next level? Join our dynamic team at Oncode Institute!

What happens when a gene guards its own power source? Researchers discovered that Sox2 keeps its enhancer in check, revealing new rules of genome organization.

Could tiny molecules from your gut decide whether cancer treatment works? New research suggests they just might.

How can scientists unlock gene regulation secrets in our DNA? At the Oncode Masterclass, researchers explored ATAC-seq to study chromatin accessibility.

Could timing chemo with the menstrual cycle improve breast cancer treatment? That’s the bold question Oncode Researcher Laura Bornes was addressing during her PhD.